Clinical Trial Update: Subcutaneous Versus Intravenous Morphine When Switching From Oral to Parenteral Route in Palliative Cancer Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing subcutaneous versus intravenous morphine for switching from oral to parenteral administration in palliative cancer patients has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Morphine (morphine)

Snippet

Sponsor: University Hospital, Akershus | Conditions: Pain Cancer | Phase 3 | Status: COMPLETED